These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8195584)

  • 1. Adverse experiences during treatment with zimeldine on special licence in Sweden.
    Bengtsson BO; Wiholm BE; Myrhed M; Wålinder J
    Int Clin Psychopharmacol; 1994; 9(1):55-61. PubMed ID: 8195584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine.
    Bengtsson BO; Lundmark J; Wålinder J
    Br J Psychiatry; 1991 Jun; 158():853-5. PubMed ID: 1831396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre double-blind comparative trial of zimeldine and imipramine in primary major depressive disorders.
    Hiramatsu KI; Takahashi R; Mori A; Inoue R; Kazamatsuri H; Murasaki M; Sakuma A
    Acta Psychiatr Scand Suppl; 1983; 308():41-54. PubMed ID: 6230895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zimeldine versus amitriptyline in endogenous depression. A double-blind study with special reference to effects on liver function.
    Larsen FW; Hansen CE
    Acta Psychiatr Scand; 1984 Apr; 69(4):343-9. PubMed ID: 6232828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions in connection with zimeldine treatment--a review.
    Nilsson BS
    Acta Psychiatr Scand Suppl; 1983; 308():115-9. PubMed ID: 6230884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome following zimeldine treatment.
    Fagius J; Osterman PO; Sidén A; Wiholm BE
    J Neurol Neurosurg Psychiatry; 1985 Jan; 48(1):65-9. PubMed ID: 3156214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders.
    Merideth CH; Feighner JP
    Acta Psychiatr Scand Suppl; 1983; 308():70-9. PubMed ID: 6230897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specificity of the zimelidine reaction.
    Montgomery SA; Gabriel R; James D; Hawley C; Burkitt P
    Int Clin Psychopharmacol; 1989 Jan; 4(1):19-23. PubMed ID: 2531772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new antidepressant zimeldine in general practice. A surveillance study of 15,000 patients.
    Fünfgeld EW
    Acta Psychiatr Scand Suppl; 1983; 308():96-103. PubMed ID: 6230899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zimeldine in depressive illness--efficacy and safety data.
    Burrows GD; Norman TR; Marriott PF; Davies B
    Acta Psychiatr Scand Suppl; 1983; 308():31-40. PubMed ID: 6230894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of zimeldine and its metabolites on [3H]thymidine incorporation in lymphocyte cultures from psychiatric patients with or without a hypersensitivity reaction during zimeldine therapy.
    Kristofferson A; Sohl-Akerlund A; Hall E; Bengtsson BO; Ogenstad S; Wålinder J
    Int Clin Psychopharmacol; 1994 Sep; 9(3):179-85. PubMed ID: 7814827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of zimeldine in long-term use in depressive illness.
    Wålinder J; Arberg-Wistedt A; Jozwiak H; von Knorring L; Nyström C
    Acta Psychiatr Scand Suppl; 1983; 308():147-60. PubMed ID: 6230889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms--a combined analysis of four British clinical trials in depression.
    Huitfeldt B; Montgomery SA
    Acta Psychiatr Scand Suppl; 1983; 308():55-69. PubMed ID: 6230896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zimeldine versus nomifensine. A double-blind study of depressed inpatients.
    Knudsen P; Bjørndal N; Johnsen T; Pfeiffer Petersen K
    Neuropsychobiology; 1984; 11(4):236-42. PubMed ID: 6238240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of multisystemic reactions to zimeldine.
    Langlois R; Cournoyer G; de Montigny C; Caillé G
    Eur J Clin Pharmacol; 1985; 28(1):67-71. PubMed ID: 3157576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zimeldine tolerability in comparison to amitriptyline and placebo: findings from a multicentre trial.
    Claghorn J; Gershon S; Goldstein BJ
    Acta Psychiatr Scand Suppl; 1983; 308():104-14. PubMed ID: 6230883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of bipolar affective illness with zimeldine, a 5-HT uptake inhibitor.
    Coppen A; Abou-Saleh MT; Wood KM; Mitchell MJ
    J Affect Disord; 1984 Dec; 7(3-4):339-42. PubMed ID: 6241215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity to zimelidine without cross reactivity to fluoxetine.
    Montgomery SA; Gabriel R; James D; Hawley C; Burkitt P
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():27-9. PubMed ID: 2521657
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects.
    Nyström C; Hällström T
    Acta Psychiatr Scand; 1985 Jul; 72(1):6-15. PubMed ID: 2930998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of zimeldine in preventing depressive episodes in recurrent major depressive disorders--a double-blind placebo-controlled study.
    Björk K
    Acta Psychiatr Scand Suppl; 1983; 308():182-9. PubMed ID: 6230892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.